LCJ: Tissue Expander And Accessories
What it covers
FDA’s classification database gives LCJ no definition, and the code has no classification regulation. Its name is “Tissue Expander And Accessories”; the recent clearances below show what has been cleared under it.
FDA flags LCJ devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K254126 | Natrelle 133S Tissue Expanders | AbbVie | Jan 16, 2026 | Special |
| K242963 | MENTOR PliaForm Breast Tissue Expander w/ Suture Tabs | Mentor Worldwide, LLC | Apr 24, 2025 | Traditional |
| K243836 | Mentor CPX 4 PLUS Enhance Breast Tissue Expander | Mentor Worldwide, LLC | Jan 12, 2025 | Special |
| K241918 | MENTOR CPX4 PLUS Enhance Breast Tissue Expander | Mentor Worldwide, LLC | Aug 2, 2024 | Special |
| K211676 | Motiva Flora SmoothSilk Tissue Expander | Motiva USA, LLC | Oct 13, 2023 | Traditional |
| K214124 | AlloX2 Pro Tissue Expanders | Sientra, Inc. | Jun 8, 2023 | Traditional |
| K221127 | Sientra, inc. Portfinder | Sientra, Inc. | May 10, 2023 | Traditional |
| K180826 | Natrelle 133 Plus MICROCELL Tissue Expander | Allergan | Dec 21, 2018 | Traditional |
| K182335 | CPX 4 Breast Tissue Expander with Smooth Surface | Mentor Worldwide, LLC | Sep 25, 2018 | Special |
| K182054 | Natrelle 133S Tissue Expander | Allergan | Aug 29, 2018 | Special |
Clearances by year
21 LCJ 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 28 |
| 2025 | 2 | 121 |
| 2024 | 1 | 32 |
| 2023 | 3 | 525 |
| 2018 | 3 | 29 |
| 2016 | 3 | 153 |
| 2015 | 2 | 150 |
| 2014 | 3 | 256 |
| 2013 | 1 | 17 |
| 2012 | 1 | 344 |
| 2011 | 1 | 99 |
Who submits
12 applicants cleared a LCJ device since 2011. 100% of the clearances went to applicants in United States. By type: Traditional 57% and Special 43%.
| Applicant | Clearances since 2011 |
|---|---|
| Mentor Worldwide, LLC | 8 |
| Allergan | 2 |
| Sientra, Inc. | 2 |
| AbbVie | 1 |
| Allergan Medical | 1 |
| Allergan, Inc. | 1 |
| Lifecell Corp. | 1 |
| Marz Medical, Inc. | 1 |
Standards
LCJ has no classification regulation naming standards. Check FDA’s recognized standards database, or ask which standards recent LCJ clearances declared.
Ask about LCJ
Questions about LCJ
What is FDA product code LCJ?
Product code LCJ, “Tissue Expander And Accessories” in FDA's classification database, is an unclassified device type, reviewed by FDA's Unknown panel. FDA's 510(k) database lists 55 clearances under LCJ, 21 of them since 2011.
How many 510(k) clearances are there under LCJ?
FDA’s 510(k) database listed 55 clearances under LCJ as of Oct 29, 2026, 21 of them decided since 2011; the most recent decision was Jan 16, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a LCJ 510(k)?
For the 3 LCJ clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 30 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most LCJ clearances?
Since 2011: Mentor Worldwide, LLC (8), Allergan (2), Sientra, Inc. (2), AbbVie (1) and Allergan Medical (1). 12 applicants have cleared a LCJ device in that time.